Gå direkt till innehåll

Kategorier: adjuvant

  • Impressive results in new Vaccine publication

    Impressive results in new Vaccine publication

    In a recently published article in Vaccine the clinical phase I results with our new oral vaccine against ETEC is presented.The results show that the vaccine was safe, well tolerated and broadly immunogenic – a result that highly exceeded the expectations. The vaccine will be tested in a Phase I/II trials in Bangladesh during next year and in travelers to ETEC-endemic areas the year after.